𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Establishment of an androgen-responsive prostatic cell line “PEA5” from a p53-deficient mouse

✍ Scribed by Makoto Hanazono; Rie Nozawa; Reiko Itakura; Shinichi Aizawa; Yasuhiro Tomooka

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
616 KB
Volume
46
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment of prostatic cell line “Pr
Establishment of prostatic cell line “Pro9ad” from a p53-deficient mouse
✍ Hanazono, Makoto; Nakagawa, Eriko; Aizawa, Shinichi; Tomooka, Yasuhiro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

## Background: We demonstrated that p53-deficiency is sufficient for immortalization of fetal uterine cells. in the present study, we further extended our previous observations to prostate tissues from a young p53-deficient adult mouse. ## Methods: Cell lines were established from the ventral pro

Generation and characterization of a mic
Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse
✍ Keiko Ohsawa; Yoshinori Imai; Kazuyuki Nakajima; Shinichi Kohsaka 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 947 KB

We have established a cell line cloned from primary-cultured microglia obtained from p53-deficient mice. The cell line, MG5, could be grown in astrocyteconditioned medium and has been maintained for more than a year. MG5 cells are immunocytochemically positive for Mac-1 and F4/80 antibody and expres

The novel heterodinucleoside dimer 5-FdU
The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145
✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell